Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression
Progress in Transplantation · 2026-06 · 36 (2) · 74-80
DOI: 10.1177/15269248261456512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Transplantation, online erschienen am 04.06.2026. Verfasst von Christy Ilia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Antilymphocyte Serum, Immunosuppressive Agents, Cost Savings. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Rabbit anti-thymocyte globulin (rATG) induction ideal dosing strategies in kidney transplant recipients have not been fully elucidated. Project Aims This study compares the impact of ideal body weight-based versus actual body weight-based rATG dosing on drug purchasing costs and kidney transplant outcomes.
Design
Retrospective, single-center chart review of kidney transplant recipients receiving rATG induction using (1) actual body weight-based dosing between May 17, 2019, and Mar 13, 2020, versus (2) ideal body weight-based dosing between May 17, 2022, and Mar 13, 2023. The primary endpoint is the rATG drug cost/kidney transplant recipient [measured by average wholesale price] compared between cohorts. Secondary endpoints are rates of biopsy-proven acute rejection, readmissions secondary to infection, myelosuppression (leukopenia or neutropenia), and viremia (Epstein-Barr virus, cytomegalovirus, and BK virus) measured for 6 months. Study design adhered to EQUATOR STROBE guidelines for reporting cohort studies.
Results
Overall, rATG ideal body weight-based dosing resulted in a median $3838 saved per kidney transplant recipients, based on average wholesale price, and a statistically significant reduction in cost versus actual body weight-based dosing ( P = .02). Secondary outcomes were generally similar between groups, with a difference in Epstein-Barr viremia ( P = .017) not translating to a significant difference in readmissions for infection ( P = .226).
Conclusion
Our institution conducts around 250 kidney transplants annually, and considering the majority will receive rATG induction, this dosing protocol estimates average wholesale price drug purchasing cost-savings of about $900 000/year without compromising early clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
- Penn Transplant Institute, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
- Division of Renal and Hypertension, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Division of Transplant Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Ciara Walshe, Jennifer Trofe, Gregory Malat
Zitieren
APA
Ilia, C., Walshe, C., Nguyen, L., Sammons, C., Norris, M., Forte, A., Trofe, J., & Malat, G. (2026). Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression. Progress in Transplantation, 36(2), 74-80. https://doi.org/10.1177/15269248261456512
Vancouver
Ilia C, Walshe C, Nguyen L, Sammons C, Norris M, Forte A, et al. Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression. Progress in Transplantation. 2026;36(2):74-80. doi:10.1177/15269248261456512
BibTeX
@article{Ilia2026,
author = {Ilia, Christy and Walshe, Ciara and Nguyen, Linh and Sammons, Chelsea and Norris, Maxwell and Forte, Abigail and Trofe, Jennifer and Malat, Gregory},
title = {Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression},
journal = {Progress in Transplantation},
year = {2026},
volume = {36},
number = {2},
pages = {74--80},
doi = {10.1177/15269248261456512}
}
EUVIMED